New Year Bumper Sale @ Rs. 1 X
Mikastar 500 Injection is a commercial drug that is prescribed in the form of Injection. It is typically used for the treatment of Urinary Tract Infection. Mikastar 500 Injection also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Mikastar 500 Injection. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. This information has been provided in detail in the dosage section.
Apart from the aforementioned side effects, Mikastar 500 Injection can also lead to other problems, which have been listed below. Usually, these side effects of Mikastar 500 Injection go away soon, and do not persist beyond the duration of the treatment. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Mikastar 500 Injection is Severe for pregnant women and Unknown for women who are breastfeeding. Warnings related to Mikastar 500 Injection's effects on the liver, heart and kidney, if any, have been listed below.
Mikastar 500 Injection is not recommended if you suffer from certain medical conditions as it can have adverse effects. Dehydration, Parkinson's Disease, Hearing Loss are examples of such conditions. The section on Mikastar 500 Injection contraindications lists all such conditions.
Drug reaction of Mikastar 500 Injection with other medicines has been reported. Refer to the list below for further details.
In addition to the above precautions for Mikastar 500 Injection, it is important to know that it is safe while driving, and is habit-forming.
Mikastar 500 Injection is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Infant (1 month to 2 years) |
|
Neonates (0 to 1 month) |
|
2 - 12 years (Child) |
|
Is the use of Mikastar 500 Injection safe for pregnant women?
Mikastar can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Mikastar 500 Injection safe during breastfeeding?
In the absence of any scientific study about the side effects of Mikastar in breastfeeding women, information on safety of Mikastar is unavailable.
What is the effect of Mikastar 500 Injection on the Kidneys?
Effects of Mikastar on kidney can be severe. It is not safe to use it without doctor's advice.
What is the effect of Mikastar 500 Injection on the Liver?
Side effects of Mikastar rarely affect the liver.
What is the effect of Mikastar 500 Injection on the Heart?
Mikastar has very mild side effects on the heart.
Mikastar 500 Injection should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take Mikastar 500 Injection unless your doctor advises you to do so -
Is this Mikastar 500 Injection habit forming or addictive?
Mikastar 500 Injection is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Mikastar 500 Injection will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, Mikastar 500 Injection is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
No, the use of Mikastar 500 Injection in mental disorders is not effective.
Interaction between Food and Mikastar 500 Injection
Taking Mikastar 500 Injection with food is safe.
Interaction between Alcohol and Mikastar 500 Injection
Due to lack of research, there is no information about the side effects of taking Mikastar 500 Injection with alcohol.
Mikastar can be safely taken as prescribed by your doctor. Do not discontinue the medicine suddenly or take it longer than prescribed duration.
Do not self-administer Mikastar. It comes in the form of injection and given preferably 2 - 3 times in a day (Intravenously). Discontinuing the medicine in between may promote resistant bacteria which result in a relapse of the infection. You are recommended to complete the 7 - 10 days course even after getting symptomatic relief. In case you feel any discomfort such as hearing loss and nephrotoxicity while taking Mikastar please inform your doctor immediately.
Mikastar is a brand name for amikacin. It is a prescription drug which belongs to the class of medication known as an aminoglycoside antibiotic. It is a broad spectrum antibiotic which is used for the treatment of bacterial infection such as bone, joint, skin, intra-abdominal, pneumonia, and respiratory tract infection. It is used for short-term treatment (7 - 10 days) of bacterial infection in different part of the body. It is also used for the treatment of neonatal sepsis when sensitivity testing indicates that other aminoglycosides cannot be used.
Yes, Mikastar is safe to use, if taken in prescribed amount and duration as advised by the doctor. However, certain side effects have been associated with this drug such as decreased urination, itching, irritation, and hearing loss. If you experience above-mentioned side after consuming this medicine then inform your doctor and follow his/her instructions.
Yes, Mikastar has been reported to cause diarrhoea and it is a common side effect of this medicine. Drink plenty of fluids while you are taking this medicine. If you are experiencing severe diarrhoea after using this drug, discuss with your doctor immediately without any further delay.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Arikayce (amikacin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 749
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 136-137